These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3407 related articles for article (PubMed ID: 7288444)

  • 1. Marine animal biosynthetic constituents for cancer chemotherapy.
    Pettit GR; Kamano Y; Fujii Y; Herald CL; Inoue M; Brown P; Gust D; Kitahara K; Schmidt JM; Doubek DL; Michel C
    J Nat Prod; 1981; 44(4):482-5. PubMed ID: 7288444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and structure of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16.
    Pettit GR; Xu JP; Hogan F; Williams MD; Doubek DL; Schmidt JM; Cerny RL; Boyd MR
    J Nat Prod; 1997 Aug; 60(8):752-4. PubMed ID: 9287413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.
    Pettit GR; Hogan F; Toms S
    J Nat Prod; 2011 May; 74(5):962-8. PubMed ID: 21534541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
    Beckwith M; Urba WJ; Longo DL
    J Natl Cancer Inst; 1993 Mar; 85(6):483-8. PubMed ID: 8445676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic Agents. 510. Isolation and structure of dolastatin 19 from the Gulf of California sea hare Dolabella auricularia.
    Pettit GR; Xu JP; Doubek DL; Chapuis JC; Schmidt JM
    J Nat Prod; 2004 Aug; 67(8):1252-5. PubMed ID: 15332837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
    Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
    Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
    Bai R; Friedman SJ; Pettit GR; Hamel E
    Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-tumor marine natural products].
    Kitagawa I; Kobayashi M
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):322-9. PubMed ID: 2310201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides.
    Horgen FD; Kazmierski EB; Westenburg HE; Yoshida WY; Scheuer PJ
    J Nat Prod; 2002 Apr; 65(4):487-91. PubMed ID: 11975485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and X-ray crystal structure of the dolabellaauricularia peptide dolastatin 18.
    Pettit GR; Hogan F; Herald DL
    J Org Chem; 2004 Jun; 69(12):4019-22. PubMed ID: 15176826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents 365. Dolastatin 10 SAR probes.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
    Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dolastatins, a family of promising antineoplastic agents.
    Poncet J
    Curr Pharm Des; 1999 Mar; 5(3):139-62. PubMed ID: 10066887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry.
    Gao G; Wang Y; Hua H; Li D; Tang C
    Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic dolastatins: potent inhibitors of hematopoietic progenitor cells.
    Jacobsen SE; Ruscetti FW; Longo DL; Keller JR
    J Natl Cancer Inst; 1991 Nov; 83(22):1672-7. PubMed ID: 1749020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
    Turner T; Jackson WH; Pettit GR; Wells A; Kraft AS
    Prostate; 1998 Feb; 34(3):175-81. PubMed ID: 9492845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic agents, 116. An evaluation of the marine ascidian Aplidium californicum.
    Pettit GR; Leet JE; Herald CL; Kamano Y; Doubek DL
    J Nat Prod; 1986; 49(2):231-5. PubMed ID: 3734809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of the nickel-chlorin chelate tunichlorin from the South Pacific ocean sea hare Dolabella auricularia.
    Pettit GR; Kantoci D; Doubek DL; Tucker BE; Pettit WE; Schroll RM
    J Nat Prod; 1993 Nov; 56(11):1981-4. PubMed ID: 8289065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors.
    Pettit GR; Melody N; Chapuis JC
    J Nat Prod; 2017 Mar; 80(3):692-698. PubMed ID: 28211277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.
    Luesch H; Harrigan GG; Goetz G; Horgen FD
    Curr Med Chem; 2002 Oct; 9(20):1791-806. PubMed ID: 12369878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 171.